Right Ventricular Function of Patients With Multiple Myeloma Treated With Carfilzomib
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 36
- 试验地点
- 1
- 主要终点
- tricuspid annular plane systolic excursion
研究概览
简要总结
Patients treated for multiple myeloma in the second line with carfilzomib may develop pulmonary hypertension. This is well documented in the literature. However, there are no studies looking at right ventricular function in these patients, both before and during treatment.
详细描述
Patients treated for multiple myeloma in the second line with carfilzomib may develop pulmonary hypertension. This is well documented in the literature. However, there are no studies looking at right ventricular function in these patients, both before and during treatment.
Patients had a cardiac ultrasound scan prior to the introduction of carfilzomib and an ultrasound scan following the introduction of carfilzomib. We will look at the evolution of right ventricular function parameters in these patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients treated for multiple myeloma with carfilzomib
- •Patients with echocardiogram before and under treatment.
排除标准
- 未提供
结局指标
主要结局
tricuspid annular plane systolic excursion
时间窗: 6 months after carfilzomib treatment
measurement of tricuspid annular plane systolic excursion by echocardiography
次要结局
未报告次要终点